Chimera BioTechnology, Inc.
rFVIIa analog hemostatic agent (recombinant Factor VIIa variant with modified domain structure to reduce thrombogenic risk)
- Sector
- Biotech
- Total capital
- $528K
- Grants
- $528K
- 4 awards
- 4.0× sector median 1 award
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median 2 patents
Capital Timeline
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Non-Thrombogenic Properties of Chimeric FVIIa | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Chimeric FVIIa | $1,300 | |
| Federal grant | Department of Health and Human Services · Phase I · Chimeric FVIIa | $75,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Chimeric FVIIa | $226,300 |
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1085 | RERX THERAPEUTICS, INC | — | — |
| 1086 | MOLECULAR INTELLIGENCE LLC | — | — |
| 1087 | ENVISBIO LLC | — | — |
| 1088 | Chimera BioTechnology, Inc. | — | — |
| 1089 | Rattan Life Science Inc. | — | — |
| 1090 | KOI BIOTHERAPEUTICS INC. | — | — |
| 1091 | VIVERE ONCOTHERAPIES, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
No people are linked to this company yet.
People appear here when they are named as related persons in the company's own Form D filings. We don't infer people from social profiles.
Checked: SEC EDGAR Form D related persons through
Patents
No patents are on record under this company's name.
USPTO publishes applications about 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won't match.
Checked: USPTO granted patents and published applications
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.